|
시장보고서
상품코드
1762470
세계의 두개내 동맥류 시장 : 시장 규모, 점유율 및 동향, 업계 분석(유형별·최종 용도별, 지역별), 예측(2025-2034년)Intracranial Aneurysm Market Size, Share, & Industry Analysis Report: By Type (Surgical Clipping, Endovascular Coiling, Flow Diverters, and Others), By End-Use, and By Region- Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면, 세계 두개내 동맥류 시장 규모는 2034년까지 39억 2,883만 달러에 달할 것으로 예측됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.
두개내 동맥류 시장은 약해지고 부풀어 오른 뇌혈관(두개내 동맥류 또는 뇌동맥류)을 진단하고 치료하는 데 사용되는 다양한 의료 제품 및 시술에 초점을 맞추었습니다. 이러한 동맥류는 파열 가능성으로 인해 심각한 건강 위험을 초래하고 출혈성 뇌졸중이나 사망과 같은 심각한 신경학적 손상을 유발할 수 있습니다. 이 시장에는 첨단 신경 영상 기술과 같은 다양한 진단 도구와 외과적 클리핑, 코일 색전술 및 유량 전환술과 같은 혈관 내 치료와 같은 치료적 개입이 포함됩니다. 이 시장의 주요 목표는 동맥류 파열을 예방하고 파열이 발생했을 때 그 영향을 관리할 수 있는 효과적인 솔루션을 제공하는 것입니다.
뇌혈관 질환에 대한 인식 증가와 첨단 진단 기술의 발달로 동맥류 조기 발견에 기여하고 있습니다. 또한, 고혈압, 흡연과 같은 위험인자의 유병률 증가, 고령화 인구 증가로 인해 이러한 질환의 위험에 노출될 수 있는 인구가 증가하고 있습니다. 또한, 의료기기의 지속적인 발전과 환자의 예후를 개선하고 회복 시간을 단축하는 최소 침습적 치료 옵션에 대한 선호도가 높아지면서 시장을 주도하고 있습니다. 이러한 역학은 두개내 동맥류 시장에서 혁신적인 솔루션의 개발 및 채택을 형성하고 있습니다.
두개내 동맥류 시장 : 분석 개요
유형별로는 혈관 내 코일 색전술이 현재 세계 최대 시장 점유율을 차지하고 있습니다. 이러한 우위는 주로 최소침습적 시술에 대한 선호도 증가와 다양한 동맥류 특성에 대한 코일 색전술의 폭넓은 적용성에 기인합니다.
최종 용도별로는 병원이 가장 큰 시장 점유율을 차지하고 있습니다. 이는 파열 및 미파열 두개내 동맥류의 진단과 종합적인 관리에 필수적인 첨단 신경영상진단 및 신경외과 인프라가 병원에 집중되어 있기 때문입니다.
지역별로는 북미 두개내 동맥류 시장이 2024년 가장 큰 매출 점유율을 차지했습니다. 아시아태평양은 두개내 동맥류 시장에서 가장 높은 성장률을 보였습니다.
두개내 동맥류 시장에서 활동하는 주요 기업으로는 Medtronic plc,Stryker Corporation,Johnson & Johnson(CERENOVUS),Terumo Corporation(MicroVention Inc.),B. Braun Melsungen AG, MicroPort Scientific Corporation, Integra LifeSciences Corporation(Codman Neuro), Penumbra, Inc. 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 분석 방법
제4장 세계의 두개내 동맥류 시장 인사이트
- 시장 현황
- 두개내 동맥류 시장 역학
- 성장 촉진요인과 기회
- 성장 억제요인과 과제
- PESTLE 분석
- 두개내 동맥류 시장 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 두개내 동맥류 시장 : 유형별
- 주요 분석 결과
- 서론
- 외과적 클리핑
- 혈관내 코일 색전술
- 혈류 전환기
- 기타
제6장 세계의 두개내 동맥류 시장 : 최종 용도별
- 주요 분석 결과
- 서론
- 병원
- 클리닉
- 기타
제7장 세계의 두개내 동맥류 시장 : 지역별
- 주요 분석 결과
- 서론
- 두개내 동맥류 시장 분석 : 지역별(2020-2034년)
- 북미
- 북미 : 유형별(2020-2034년)
- 북미 : 최종 최종 용도별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 유형별(2020-2034년)
- 유럽 : 최종 용도별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 유형별(2020-2034년)
- 아시아태평양 : 최종 용도별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 유형별(2020-2034년)
- 중동 및 아프리카 : 최종 용도별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 유형별(2020-2034년)
- 라틴아메리카 : 최종 용도별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제8장 경쟁 구도
- 사업 확대 및 기업 인수 분석
- 사업 확대
- 기업 인수
- 제휴/협업/합의/공개
제9장 기업 개요
- B. Braun Melsungen AG
- Integra LifeSciences Corporation(Codman Neuro)
- Johnson & Johnson(CERENOVUS)
- Kaneka Corporation
- Medtronic plc
- MicroPort Scientific Corporation
- Penumbra, Inc.
- Phenox GmbH
- Stryker Corporation
- Terumo Corporation(MicroVention Inc.)
The global intracranial aneurysm market size is expected to reach USD 3,902.83 Million by 2034, according to a new study by Polaris Market Research. The report "Intracranial Aneurysm Market Size, Share, Trends, Industry Analysis Report: By Type (Surgical Clipping, Endovascular Coiling, Flow Diverters, and Others), End-Use, and Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The intracranial aneurysm market focuses on the range of medical products and procedures used to diagnose and treat weakened, bulging blood vessels in the brain, known as intracranial or cerebral aneurysms. These aneurysms pose a significant health risk due to the possibility of rupture, which can lead to severe neurological damage, including hemorrhagic stroke and death. The market includes various diagnostic tools, such as advanced neuroimaging techniques, as well as therapeutic interventions like surgical clipping and endovascular treatments, including coil embolization and flow diversion. The primary objective of this market is to provide effective solutions for preventing aneurysm rupture and managing the consequences if a rupture occurs.
Increased awareness of cerebrovascular diseases and the availability of advanced diagnostic technologies are contributing to earlier detection of aneurysms. Additionally, the rising prevalence of risk factors such as hypertension and smoking, along with a growing aging population, is increasing the number of individuals at risk for these conditions. The market is further driven by continual advancements in medical devices and a rising preference for minimally invasive treatment options, which offer improved patient outcomes and shorter recovery times. These dynamics are shaping the development and adoption of innovative solutions within the intracranial aneurysm market.
Intracranial Aneurysm Market Report Highlights:
By type, the endovascular coiling subsegment currently holds the largest market share globally. This dominance is primarily driven by the increasing preference for minimally invasive procedures and the broad applicability of coil embolization across various aneurysm characteristics.
By end-use, the hospitals subsegment accounts for the largest market share. This is due to the concentration of advanced neuroimaging and neurosurgical infrastructure in hospitals, which are essential for the diagnosis and comprehensive management of both ruptured and unruptured intracranial aneurysms.
By region, North America intracranial aneurysm market held the largest revenue share in 2024. The Asia Pacific region is witnessing the highest growth rate in the intracranial aneurysm market.
Some of the major players currently active in the intracranial aneurysm market include Medtronic plc, Stryker Corporation, Johnson & Johnson (CERENOVUS), Terumo Corporation (MicroVention Inc.), B. Braun Melsungen AG, MicroPort Scientific Corporation, Integra LifeSciences Corporation (Codman Neuro), Penumbra, Inc., Kaneka Corporation, and Phenox GmbH.
Polaris Market Research has segmented the Intracranial Aneurysm market report based on type, end-use, and region:
By Type Outlook (Revenue - USD Million, 2020-2034)
Surgical Clipping
Endovascular Coiling
Flow Diverters
Others
By End-Use Outlook (Revenue - USD Million, 2020-2034)
Hospitals
Clinics
Others
By Regional Outlook (Revenue - USD Million, 2020-2034)
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Intracranial Aneurysm Market Insights
- 4.1. Intracranial Aneurysm Market - Market Snapshot
- 4.2. Intracranial Aneurysm Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Prevalence of Intracranial Aneurysms
- 4.2.1.2. Advancements in Neurovascular Imaging Technologies
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Limited awareness
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Intracranial Aneurysm Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Intracranial Aneurysm Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 5.3. Surgical Clipping
- 5.3.1. Global Intracranial Aneurysm Market, by Surgical Clipping, by Region, 2020-2034 (USD Million)
- 5.4. Endovascular Coiling
- 5.4.1. Global Intracranial Aneurysm Market, by Endovascular Coiling, by Region, 2020-2034 (USD Million)
- 5.5. Flow Diverters
- 5.5.1. Global Intracranial Aneurysm Market, by Flow Diverters, by Region, 2020-2034 (USD Million)
- 5.6. Others
- 5.6.1. Global Intracranial Aneurysm Market, by Others, by Region, 2020-2034 (USD Million)
6. Global Intracranial Aneurysm Market, by End-Use
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 6.3. Hospitals
- 6.3.1. Global Intracranial Aneurysm Market, by Hospitals, by Region, 2020-2034 (USD Million)
- 6.4. Clinics
- 6.4.1. Global Intracranial Aneurysm Market, by Clinics, by Region, 2020-2034 (USD Million)
- 6.5. Others
- 6.5.1. Global Intracranial Aneurysm Market, by Others, by Region, 2020-2034 (USD Million)
7. Global Intracranial Aneurysm Market, by Geography
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Intracranial Aneurysm Market Assessment, By Geography, 2020-2034 (USD Million)
- 7.3. Intracranial Aneurysm Market - North America
- 7.3.1. North America: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.3.2. North America: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.3.3. Intracranial Aneurysm Market - U.S.
- 7.3.3.1. U.S.: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.3.3.2. U.S.: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.3.4. Intracranial Aneurysm Market - Canada
- 7.3.4.1. Canada: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.3.4.2. Canada: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.4. Intracranial Aneurysm Market - Europe
- 7.4.1. Europe: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.4.2. Europe: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.4.3. Intracranial Aneurysm Market - UK
- 7.4.3.1. UK: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.4.3.2. UK: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.4.4. Intracranial Aneurysm Market - France
- 7.4.4.1. France: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.4.4.2. France: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.4.5. Intracranial Aneurysm Market - Germany
- 7.4.5.1. Germany: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.4.5.2. Germany: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.4.6. Intracranial Aneurysm Market - Italy
- 7.4.6.1. Italy: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.4.6.2. Italy: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.4.7. Intracranial Aneurysm Market - Spain
- 7.4.7.1. Spain: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.4.7.2. Spain: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.4.8. Intracranial Aneurysm Market - Netherlands
- 7.4.8.1. Netherlands: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.4.8.2. Netherlands: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.4.9. Intracranial Aneurysm Market - Russia
- 7.4.9.1. Russia: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.4.9.2. Russia: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.4.10. Intracranial Aneurysm Market - Rest of Europe
- 7.4.10.1. Rest of Europe: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.4.10.2. Rest of Europe: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.5. Intracranial Aneurysm Market - Asia Pacific
- 7.5.1. Asia Pacific: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.5.2. Asia Pacific: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.5.3. Intracranial Aneurysm Market - China
- 7.5.3.1. China: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.5.3.2. China: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.5.4. Intracranial Aneurysm Market - India
- 7.5.4.1. India: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.5.4.2. India: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.5.5. Intracranial Aneurysm Market - Malaysia
- 7.5.5.1. Malaysia: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.5.5.2. Malaysia: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.5.6. Intracranial Aneurysm Market - Japan
- 7.5.6.1. Japan: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.5.6.2. Japan: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.5.7. Intracranial Aneurysm Market - Indonesia
- 7.5.7.1. Indonesia: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.5.7.2. Indonesia: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.5.8. Intracranial Aneurysm Market - South Korea
- 7.5.8.1. South Korea: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.5.8.2. South Korea: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.5.9. Intracranial Aneurysm Market - Australia
- 7.5.9.1. Australia: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.5.9.2. Australia: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.5.10. Intracranial Aneurysm Market - Rest of Asia Pacific
- 7.5.10.1. Rest of Asia Pacific: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.5.10.2. Rest of Asia Pacific: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.6. Intracranial Aneurysm Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.6.2. Middle East & Africa: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.6.3. Intracranial Aneurysm Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.6.3.2. Saudi Arabia: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.6.4. Intracranial Aneurysm Market - UAE
- 7.6.4.1. UAE: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.6.4.2. UAE: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.6.5. Intracranial Aneurysm Market - Israel
- 7.6.5.1. Israel: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.6.5.2. Israel: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.6.6. Intracranial Aneurysm Market - South Africa
- 7.6.6.1. South Africa: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.6.6.2. South Africa: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.6.7. Intracranial Aneurysm Market - Rest of Middle East & Africa
- 7.6.7.1. Rest of Middle East & Africa: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.6.7.2. Rest of Middle East & Africa: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.7. Intracranial Aneurysm Market - Latin America
- 7.7.1. Latin America: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.7.2. Latin America: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.7.3. Intracranial Aneurysm Market - Mexico
- 7.7.3.1. Mexico: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.7.3.2. Mexico: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.7.4. Intracranial Aneurysm Market - Brazil
- 7.7.4.1. Brazil: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.7.4.2. Brazil: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.7.5. Intracranial Aneurysm Market - Argentina
- 7.7.5.1. Argentina: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.7.5.2. Argentina: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
- 7.7.6. Intracranial Aneurysm Market - Rest of Latin America
- 7.7.6.1. Rest of Latin America: Intracranial Aneurysm Market, by Type, 2020-2034 (USD Million)
- 7.7.6.2. Rest of Latin America: Intracranial Aneurysm Market, by End-Use, 2020-2034 (USD Million)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. B. Braun Melsungen AG
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Integra LifeSciences Corporation (Codman Neuro)
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Johnson & Johnson (CERENOVUS)
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Kaneka Corporation
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Medtronic plc
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. MicroPort Scientific Corporation
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Penumbra, Inc.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Phenox GmbH
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Stryker Corporation
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Terumo Corporation (MicroVention Inc.)
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
